Docetaxel-induced onycholysis: The role of subungual hemorrhage and suppuration

被引:17
|
作者
Roh, Mi Ryung
Cho, Jae Yong
Lew, Wook
机构
[1] Yonsei Univ, Coll Med, Dept Dermatol, Seoul 135720, South Korea
[2] Yonsei Univ, Coll Med, Dept Med Oncol, Seoul 135720, South Korea
关键词
docetaxel; onycholysis; hemorrhage;
D O I
10.3349/ymj.2007.48.1.124
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nail changes are common side effects of taxane chemotherapeutic agents. Docetaxel (Taxotere((R))) is known to cause a great incidence of nail change. Various types of nail changes have previously been reported as a result of treatment with taxanes. We describe 2 cases of severe nail changes induced by docetaxel. The patients had previously been diagnosed with breast cancer and advanced gastric cancer, respectively. During the course of treatment with docetaxel, nail changes became apparent in both patients. Initially, they complained of nail bed purpura. Subungual hematomas with hemopurulent discharge were later observed in several fingers. Drainage of the hemopurulent material occurred spontaneously in our cases, leading to onycholysis. Following drainage, the pain in the nail with subungual hemoprulent material was relieved immediately and spontaneous healing of the patients' nails was noticed after few months. Subungual hemorrhage and suppuration therefore are considered causes of onycholysis and the pain in these patients. Although systemic or topical antibiotics were not used to treat these patients, antibiotics may be also worthwhile to hasten the drainage of the subungual hematomas and suppuration in patients for quick relief of pain.
引用
收藏
页码:124 / 126
页数:3
相关论文
共 50 条
  • [21] Docetaxel-Induced Pneumonitis in a Patient With Metastatic Lung Adenocarcinoma
    Chua, Brian
    Tan, Yi Hern
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
  • [22] Carboplatin and docetaxel-induced acute pancreatitis: brief report
    Singh, Veerpal
    Devata, Sumana
    Cheng, Yee C.
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2010, 15 (06) : 642 - 644
  • [23] Frequency and characteristics of docetaxel-induced radiation recall phenomenon
    Mizumoto, Masashi
    Harada, Hideyuki
    Asakura, Hirofumi
    Zenda, Sadamoto
    Fuji, Hiroshi
    Murayama, Shigeyuki
    Nishimura, Tetsuo
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (04): : 1187 - 1191
  • [24] Fungal immunomodulatory proteins alleviate docetaxel-induced adverse effects
    Ou, Chu-Chyn
    Hsiao, Yi-Min
    Hou, Ting-Yi
    Wu, Ming-Fang
    Ko, Jiunn-Liang
    JOURNAL OF FUNCTIONAL FOODS, 2015, 19 : 451 - 463
  • [25] Docetaxel-induced acute myositis: a case report with review of literature
    Wongsaengsak, Sariya
    Quirch, Miguel
    Ball, Somedeb
    Sultan, Anita
    Jahan, Nusrat
    Elmassry, Mohamed
    Rehman, Shabnam
    JOURNAL OF CHEMOTHERAPY, 2021, 33 (02) : 116 - 121
  • [26] Docetaxel-induced nail changes - a neurogenic mechanism: a case report
    Wasner, G
    Hilpert, F
    Schattschneider, J
    Binder, A
    Pfisterer, J
    Baron, R
    JOURNAL OF NEURO-ONCOLOGY, 2002, 58 (02) : 167 - 174
  • [27] Docetaxel-induced polyploidization may underlie chemoresistance and disease relapse
    Ogden, Angela
    Rida, Padmashree C. G.
    Knudsen, Beatrice S.
    Kucuk, Omer
    Aneja, Ritu
    CANCER LETTERS, 2015, 367 (02) : 89 - 92
  • [28] Docetaxel-induced hand foot syndrome: "No dose is a safe dose"
    Jain, Ankit
    Dubashi, Biswajit
    JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2012, 3 (02) : 200 - 201
  • [29] Pretreatment with different doses of dexamethasone in the prevention of docetaxel-induced hypersensitivity
    Zhang, Mingjun
    Chen, Zhendong
    Yang, Yang
    Cheng, Huaidong
    Li, Chao
    He, Qian
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 30 (01) : 61 - 65
  • [30] A rare case of docetaxel-induced myositis in a patient with a lung adenocarcinoma
    Ishida, Akane
    Ushio, Ayumi
    Hashimoto, Masao
    Ishii, Satoru
    Naka, Go
    Iikura, Motoyasu
    Izumi, Shinyu
    Hojo, Masayuki
    Sugiyama, Haruhito
    THORACIC CANCER, 2022, 13 (14) : 2075 - 2077